Skip to content

Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

Correlation of "Myositis Functional Index-3 (Fi-3)" With Muscle Function Assessed by Isokinetic Dynamometry and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05027152
Enrollment
2
Registered
2021-08-30
Start date
2021-09-01
Completion date
2023-09-01
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatomyositis, Idiopathic Inflammatory Myopathy, Polymyositis

Keywords

exercise, muscle function, functional capacity, quality of life

Brief summary

Idiopathic inflammatory myopathies lead to important functional limitations resulting from the loss of muscle strength and endurance, especially in the hip and shoulder, which leads to a significant loss of quality of life for patients. The aim of this study is to correlate the "Myositis Functional Index-3 (FI-3)" with muscle function assessed by computerized isokinetic dynamometry, electromyography and magnetic resonance through an observational study; and to study the effects of a repetitive task training program through an interventional study in patients with inflammatory myopathies. It is expected that FI-3 will present a good correlation with muscle function assessed by computerized isokinetic dynamometry and electromyography, given its reduced cost and less time spent on evaluation. It is also expected to demonstrate that repetitive task training is efficient and safe.

Detailed description

Idiopathic inflammatory myopathies lead to important functional limitations resulting from the loss of muscle strength and endurance, especially in the hip and shoulder, which leads to a significant loss of quality of life for patients. PURPOSE: to correlate the "Myositis Functional Index-3 (FI-3)" with muscle function assessed by computerized isokinetic dynamometry, electromyography and magnetic resonance through an observational study; and to compare the effects of a repetitive task training program with a resistance exercise program through an interventional study in patients with inflammatory myopathies. METHODS: this is an observational cross-sectional study for the observational study and an interventional study/randomized clinical trial for the interventional study. The study will be held at the Cassiano Antônio de Moraes University Hospital (HUCAM) and at the Interprofessional Health Clinic (CEIS) of the Federal University of Espírito Santo (UFES), located in the city of Vitória, Espírito Santo. Patients will come from the Rheumatology Service of HUCAM For the observational study, 30 patients with inflammatory myopathies and 15 healthy individuals matched for age and sex. For the interventional study, patients evaluated in the observational study will be invited to participate of the repetitive task training intervention. To participate in the research, patients must have a diagnosis of polymyositis or dermatomyositis (Bohan and Peter criteria); age ≥18 years; duration of disease since diagnosis for more than six months; stable medication ≥3 months; chronic inactive or mildly active but stable myositis for at least 3 months prior to observation; HAQ≥0.5. They may not have serious cardiac or pulmonary conditions; severe osteoporosis; unable to exercise; neoplasm; cognitive disorders; and acute or chronic infection. Healthy individuals must be age and sex matched with patients and may not have severe cardiac or pulmonary conditions; severe osteoporosis; unable to exercise; neoplasm; cognitive disorders; and acute or chronic infection. Patients will be evaluated in two moments: before starting the training programs and after 12 weeks. Healthy individuals will be evaluated only once. The data from the evaluations carried out before starting the training programs will be used for the analysis of the observational study. Participants will be evaluated for variables: muscle endurance (Functional Index-3 and isokinetic dynamometry), muscle strength (Manual Muscle Test 8 and isokinetic dynamometry), muscle activation (electromyography), muscle damage (magnetic resonance imaging of thigh muscles), cardiopulmonary capacity (6-minute walk test), pain (visual analogue scale), functional capacity (Health Assessment Questionnaire), quality of life (SF-36), disease activity (PGA, SGA, MDAAT, creatine phosphokinase and aldolase) and disease damage (MDI). In addition, demographic and clinical data such as date of birth, age, sex, self-reported race-color, marital status, occupational status, weight, height, date of first symptoms, date of diagnosis, comorbidities and medications in use will also be collected. The training program will last 12 weeks, twice a week in person with the supervision of physiotherapists and once a week at home. Each session will last 60 minutes. The repetitive task training group will carry out exercises involving upper and lower limbs. To determine the clinical-demographic characterization of the study population, descriptive statistics (mean and standard deviation) will be used; the correlation analysis will be performed using the Pearson or Spearman correlation coefficient; the comparison between the group of patients and the control group of healthy individuals will be performed using the t test or Mann-Whitney test; the normality test to be used will be the Shapiro-Wilk and the results will be considered significant for P\<0.05. EXPECTED RESULTS: It is expected that FI-3 will present a good correlation with muscle function assessed by computerized isokinetic dynamometry and electromyography, given its reduced cost and less time spent on evaluation. It is also expected to demonstrate that repetitive task training is efficient and safe resistance exercises.

Interventions

The repetitive task training group will carry out exercises involving upper and lower limbs.

Sponsors

Federal University of Espirito Santo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* diagnosis of polymyositis or dermatomyositis (Bohan and Peter criteria) * age ≥18 years * duration of disease since diagnosis for more than six months * stable medication ≥3 months * chronic inactive or mildly active but stable myositis for at least 3 months prior to observation * Health Assessment Questionnaire (HAQ) ≥0.5

Exclusion criteria

* serious cardiac or pulmonary conditions * severe osteoporosis * unable to exercise * neoplasm * cognitive disorders * acute or chronic infection

Design outcomes

Primary

MeasureTime frameDescription
muscle performance endurance2 years"Myositis Functional Index-3 (FI-3)"; number of repetition of each muscle group task from 0-60
computerized muscle endurance test2 years"isokinetic dynamometry"; number of repetitions of shoulder and hip flexion until exhaustion

Secondary

MeasureTime frameDescription
manual muscle strength test2 years"Manual Muscle Test 8"; Score from 0-10, higher scores mean a better outcome
computerized muscle strength test2 years"isokinetic dynamometry"; mean of 3 concentric peak torque of shoulder and hip flexion
cardiopulmonary capacity2 years"6-minute walk test"; greater time mean a better outcome
functional capacity2 years"Health Assessment Questionnaire"; Score from 0-3, score from 0-100, higher scores mean a worse outcome
quality of life level2 years"Medical Outcomes Short-Form Health Survey (SF-36)";Score from 0-100, higher scores mean a better outcome
disease activity by physician2 years"Physician Global Assessment (PGA)"; Score from 0-10, higher scores mean a worse outcome
disease activity by patient2 years"Subjective Global Assessment (SGA)"; Score from 0-10, higher scores mean a worse outcome
disease activity questionnaire2 years"Myositis Disease Activity Assessment Tool (MDAAT)"; This is a combined tool that captures the physician's assessment of disease activity of various organ systems using the 0-4 scale and a visual analog scale (VAS) from 0-10cm
laboratory parameters of disease activity I2 years"creatine phosphokinase"; units/L
laboratory parameters of disease activity II2 yearsaldolase; units/L
disease damage2 years"Myositis Damage Index (MDI)"; 10 cm visual analogue scale scores for each of the eleven individual organ systems
muscle activation2 yearselectromyography during shoulder and hip flexion; motor unit action potentials (MUAPs)
muscle damage2 yearsmagnetic resonance imaging of thigh muscles; muscle damage and fatty infiltration

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026